The LRG Board of Directors Welcomes John Abrams to the Team
GIST Mentor John Abrams joins the Board of the LRG.
GIST Mentor John Abrams joins the Board of the LRG.
Deciphera issued a press release today sharing the results of an exploratory analysis of data using circulating tumor DNA (ctDNA) from the INTRIGUE Phase 3 clinical study of ripretinib and announcing plans to initiate INSIGHT.
Our Good News Holiday Campaign is the culmination of our year of "Time to Tell the Stories 2022." In this series, we celebrate the connections, the celebrations, the events and milestones that we’ve been privileged to be a part of this year. Sarah McGoram shares her experience as a patient advocate.
Gift giving is a wonderful opportunity to share a different kind of gift, especially when considering loved ones who may be cancer patients and caregivers.
In this interview with researcher & surgical oncologist Dr. Jason Sicklick shares about his passion for SDH-deficient GIST research.
CTOS is an international group comprised of physicians and scientists with a primary interest in the tumors of connective tissues. The goal of the society is to advance the care of patients with connective tissue tumors.
After three long years, the Annual Night to Fight Cancer benefiting the LRG's research programs, hosted by Jerry Cudzil and Matthew Knopman, took place in-person on October 20th, 2022 at Midtown Loft and Terrace in New York City.
Our most recent GIST Days of Learning (GDOLs) were in-person again! Deputy Director, Laura Occhiuzzi and Senior Director of Outreach & Engagement Diana Nieves traveled to San Diego and Miami to meet with GIST experts and members of our community.
Sarah McGoram is a long-term survivor & passionate patient advocate for GIST patients in Australia.
GISTer Dina Wiley embodies all the best qualities of a patient advocate and as she retires from her volunteer work with us, we thank her for all she has done for the GIST community.